L-Satropane Prevents Retinal Neuron Damage by Attenuating Cell Apoptosis and Aβ Production via Activation of M1 Muscarinic Acetylcholine Receptor.

Abstract

Muscarinic acetylcholine receptor (mAChR) agonists have been used to treat glaucoma due to their intraocular pressure-lowering effects. Recently, it has been reported that retinal mAChRs activation can also stimulate neuroprotective pathways.

PURPOSE:

In our study, we evaluated the potential neuroprotective effect of L-satropane, a novel mAChR agonist, on retinal neuronal injury induced by cobalt chloride (CoCl2) and ischemia/reperfusion (I/R).

METHODS:

CoCl2-induced hypoxia injury in cultured cell models and I/R-induced retinal neuronal damage in rats in vivo were used to evaluate the abilities of L-satropane. In detail, we measured the occurrence of retinal pathological changes including molecular markers of neuronal apoptosis and Aβ expression.

RESULTS:

Pretreatment with L-satropane protects against CoCl2-induced neurotoxicity in PC12 and primary retinal neuron (PRN) cells in a dose-dependent manner by increasing retinal neuron survival. CoCl2 or I/R-induced cell apoptosis by upregulating Bax expression and downregulating Bcl-2 expression, which resulted in an increased Bax/Bcl-2 ratio, and upregulating caspase-3 expression/activity was significantly reversed by L-satropane treatment. In addition, L-satropane significantly inhibited the upregulation of Aβ production in both retinal neurons and tissue. We also found that I/R-induced histopathological retinal changes including cell loss in the retinal ganglion cell layer (GCL) and increased TUNEL positive retinal ganglion cells in GCL and thinning of the inner plexiform layer (IPL) and inner nuclear layer (INL) were markedly improved by L-satropane. The effects of L-satropane were largely abolished by the nonselective mAChRs antagonist atropine and M1-selective mAChR antagonist pirenzepine.

CONCLUSION:

These results demonstrated that L-satropane might be effective in preventing retinal neuron damage caused by CoCl2 or I/R. The neuroprotective effects of L-satropane may be attributed to decreasing cell apoptosis and Aβ production through activation of M1 mAChR.

• Authors: Ping Yu, Wei Zhou, Lu Liu, Ya-Bin Tang, Yun Song, Juan-Juan Lu, Li-Na Hou, Hong-Zhuan Chen, Yong-Yao Cui
• Journal: Current eye research (Curr Eye Res) Vol. 42 Issue 9 Pg. 1319-1326 (09 2017) ISSN: 1460-2202 [Electronic] England
• PMID: 28632409 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Amyloid beta-Peptides
• Muscarinic Agonists
• Neuroprotective Agents
• Receptor, Muscarinic M1
• Tropanes
• satropane

Topics

• Amyloid beta-Peptides (biosynthesis, drug effects)
• Animals
• Animals, Newborn
• Apoptosis (drug effects)
• Blotting, Western
• Cell Survival (drug effects)
• Disease Models, Animal
• Enzyme-Linked Immunosorbent Assay
• Immunohistochemistry
• In Situ Nick-End Labeling
• Muscarinic Agonists
• Neuroprotective Agents (pharmacology)
• Rats
• Rats, Sprague-Dawley
• Receptor, Muscarinic M1 (drug effects, metabolism)
• Retinal Diseases (metabolism, pathology, prevention & control)
• Retinal Ganglion Cells (drug effects, pathology)
• Retinal Neurons (drug effects, metabolism, pathology)
• Tropanes (pharmacology)